Search for content, post, videos

BioLamina announces release of first batches from new facility

BioLamina announces the release of the first Biolaminin 521 LN batches issued from its new manufacturing facility in Sundbyberg, Sweden.

The products, which are now ready for commercialization, have been produced in the latest expansion of BioLamina premises. This facility is dedicated to production and research within process development, matrix biology and cellular assays.

The 340 m² large space will also improve logistical operations and increase storage capacities.


A milestone

The opening of the new premises marks a significant milestone for BioLamina, as it scales up the company’s product production and responds to increasing demand.

“I want to thank everyone who supported this project, our partners as well as our internal team. This new facility will allow a steady increase of BioLamina’s overall production capacity, addressing our customers’ growing needs and keeping serving them with the highest quality products on their journey to success,” says Veronica Byfield Sköld, CEO of BioLamina.

Photo: BioLamina